Accuray Inc

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $212.68M
  • PE -49
  • Debt $184.56M
  • Cash $65.39M
  • EV $331.85M
  • FCF -$6.97M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$4.37M
EBIT$4.81M
ROE-9%
ROA1%
FCF-$6.97M
Equity$47.89M
Growth Stability1
PE-48.65
PEG-136.22
PB4.44
P/FCF-30.53
P/S0.47
Price/Cash0.31
Debt/Equity3.85
Debt/FCF-26.49
Net Margins-1%
Gross Margins32%
Op. Margins1%
Earnings CAGR0%
Sales Growth YoY8%
Sales Growth QoQ14%
Sales CAGR2%
FCF CAGR0%
Equity CAGR-2%
Earnings Stability0
Earnings Growth YoY-126%
Earnings Growth QoQ-164%
Earnings CAGR 5Y0%
Sales CAGR 5Y4%
FCF CAGR 5Y-7%
Equity CAGR 5Y-9%
Earnings CAGR 3Y2%
Sales CAGR 3Y2%
FCF CAGR 3Y3%
Equity CAGR 3Y-6%
Market Cap$212.68M
Revenue$453.14M
Assets$478.38M
Total Debt$184.56M
Cash$65.39M
Shares Outstanding100.8M
EV331.85M
Earnings Score6%
Moat Score18%
Safety Score59%
Final Score27%
Working Capital124.44M
Current Ratio1.62
Gross Profit$143.89M
Shares Growth 3y3%
Equity Growth QoQ6%
Equity Growth YoY0%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.

SEC Filings

Direct access to Accuray Inc (ARAY) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Accuray Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Accuray Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%
Stability 0%
loading chart...

Accuray Inc Discounted Cash Flow

Fully customizable DCF calculator online for Accuray Inc.

= -$72M
012345678910TV
fcf-$7M-$7M-$7M-$7.1M-$7.1M-$7.1M-$7.2M-$7.2M-$7.2M-$7.3M-$7.3M-$73M
DCF-$6.4M-$5.8M-$5.3M-$4.8M-$4.4M-$4M-$3.7M-$3.4M-$3.1M-$2.8M-$28M
Value-$72M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Net Margins-11%-6%-8%-6%-4%1%-2%-1%-2%-3%-1%
ROA--1%-2%-1%0%3%5%2%0%0%1%
ROE--43%-64%-49%-33%6%-9%-10%-17%-34%-9%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Debt over FCF-10.2-51.6712.33-5.19-40.25.71-27.0463.49-11.72-26.49
Debt over Equity2.844.356.013.063.543.1833.623.464.033.85
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024CAGR 5Y
Revenue YoY growth-5%-4%6%3%-9%3%8%4%-0%4%
Earnings YoY growth--37%16%-19%-31%-123%-265%-15%74%68%0%
Equity YoY growth--21%-22%5%3%28%8%-23%1%-16%-9%
FCF YoY growth--202%-121%-323%-382%-85%-820%-120%-141%-630%-7%